Up-to-date, authoritative and comprehensive, Heart Failure, 4th Edition, provides the clinically relevant information you need to effectively manage and treat patients with this complex cardiovascular problem. This fully revised companion to Braunwald’s Heart Disease helps you make the most of new drug therapies such as angiotensin receptor neprilysin inhibitors (ARNIs), recently improved implantable devices, and innovative patient management strategies. Led by internationally recognized heart failure experts Dr. G. Michael Felker and Dr. Douglas Mann, this outstanding reference gives health care providers the knowledge to improve clinical outcomes in heart failure patients. Focuses on a clinical approach to treating heart failure, resulting from a broad variety of cardiovascular problems. Covers the most recent guidelines and protocols, including significant new updates to ACC, AHA, and HFSA guidelines. Covers key topics such as biomarkers and precision medicine in heart failure and new data on angiotensin receptor neprilysin inhibitors (ARNIs). Contains four new chapters: Natriuretic Peptides in Heart Failure; Amyloidosis as a Cause of Heart Failure; HIV and Heart Failure; and Neuromodulation in Heart Failure. Covers the pathophysiological basis for the development and progression of heart failure. Serves as a definitive resource to prepare for the ABIM’s Heart Failure board exam. 2016 British Medical Association Award: First Prize, Cardiology (3rd Edition).
Benefit from the substantial experience of Elliott M. Antman, MD, Marc S. Sabatine, MD, and a host of other respected authorities, who provide practical, evidence-based rationales for all of today's clinical therapies.
Colvin-Adams M, Smith JM, Heubner BM, et al. OPTN/SRTR 2013 annual data report: heart. ... Weinhaus L, Canter C, Noetzel M, McAlister W, Spray TL. Extracorporeal membrane oxygenation for ... Kulik TJ, Moler FW, Palmisano JM, et al.
In print, more than 800 review questions - derived from the 9th Edition of Braunwald's Heart Disease - test your knowledge of all essential concepts in cardiology today.
... 0.5 Hancock Stented porcine 21 18.0 ± 6.0 12.0 ± 2.0 23 16.0 ± 2.0 11.0 ± 2.0 25 15.0 ± 3.0 10.0 ± 3.0 Hancock II Stented porcine 21 14.8 ± 4.1 1.3 ± 0.4 23 34.0 ± 13.0 16.6 ± 8.5 1.3 ± 0.4 25 22.0 ± 5.3 10.8 ± 2.8 1.6 ± 0.4 29 16.2 ...
Challenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions.
Complemented by: Braunwald's heart disease.
The third edition of Hypertension: A Companion to Braunwald's Heart Disease, by Drs. George L. Bakris and Matthew Sorrentino, focuses on every aspect of managing and treating patients who suffer from hypertensive disorders.
More than 700 questions and answers, derived from and keyed to the 12th Edition of Braunwald’s Heart Disease, provide a quick yet thorough review of essential content for contemporary cardiology practice.
Today’s patients have unique cardiologic needs before, during, and after cancer treatment.
Morrow DA, Sabatine MS, Brennan ML, et al: Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischemic ...